Silexion Therapeutics Corp (NASDAQ:SLXN) shares are moving higher on Wednesday after the company reported that Guangzhou Sino-Israel bio-industry investment fund holds a stake in the company.
The Details: According to a FormSC13D filed with the Securities and Exchange Commission, Guangzhou Sino-Israel holds a 13.8% stake in Silexion.
The company’s 13.8% stake in the company equates to 1,987,082 shares.
Silexion is trading on higher-than-normal volume at 171.05 million, compared to its average session volume of 2.73 million over the past 100 days, per data from Benzinga Pro.
How To Buy Silexion Shares
By now you're likely curious about how to participate in the market for Silexion Therapeutics (NASDAQ:SLXN) – be it to ...